filmov
tv
Nader Pouratian, MD, PhD, FAANS FACS: The Pathology of Synchrony in Parkinson Disease
Показать описание
Full talk title: “The Pathology of Synchrony in Parkinson Disease: Insights from Invasive Human Neurophysiology”
The pathophysiology underlying the motor symptoms of Parkinson’s disease (PD) remains incompletely understood with recent conflicting reports of changes in neuronal activity in distinct nodes within the basal ganglia-thalamocortical (BGTC) motor circuit. A unified approach that accounts for conflicting results is needed. Emphasizing the relatively underexplored dynamic relationship between nodes in the circuit, we build upon the hypothesis that exaggerated network-level coupling is the pathophysiologic process underlying the rigidity and bradykinesia of PD by impeding effective information flow. Accordingly, we propose that modulation of network coupling is the common therapeutic mechanism across pharmacologic and surgical therapies. We will review results implicating hypersynchrony underlying PD symptoms and changes in synchrony corresponding with therapeutic improvement. These approaches have important implications for the study of other neuropsychiatric diseases and offer important potential biomarkers to guide the development and evaluation of more advanced therapies, such as closed-loop brain stimulation.
The pathophysiology underlying the motor symptoms of Parkinson’s disease (PD) remains incompletely understood with recent conflicting reports of changes in neuronal activity in distinct nodes within the basal ganglia-thalamocortical (BGTC) motor circuit. A unified approach that accounts for conflicting results is needed. Emphasizing the relatively underexplored dynamic relationship between nodes in the circuit, we build upon the hypothesis that exaggerated network-level coupling is the pathophysiologic process underlying the rigidity and bradykinesia of PD by impeding effective information flow. Accordingly, we propose that modulation of network coupling is the common therapeutic mechanism across pharmacologic and surgical therapies. We will review results implicating hypersynchrony underlying PD symptoms and changes in synchrony corresponding with therapeutic improvement. These approaches have important implications for the study of other neuropsychiatric diseases and offer important potential biomarkers to guide the development and evaluation of more advanced therapies, such as closed-loop brain stimulation.